Profile for Australia Patent: 2013203780
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2013203780
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Jan 15, 2030 | Exelixis | COMETRIQ | cabozantinib s-malate |
⤷ Sign Up | Jan 15, 2030 | Exelixis Inc | CABOMETYX | cabozantinib s-malate |
⤷ Sign Up | Jan 15, 2030 | Exelixis | COMETRIQ | cabozantinib s-malate |
⤷ Sign Up | Jan 15, 2030 | Exelixis Inc | CABOMETYX | cabozantinib s-malate |
⤷ Sign Up | Jan 15, 2030 | Exelixis | COMETRIQ | cabozantinib s-malate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |